We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current DRUG market cap is 208.69M. The company's latest EPS is CAD -0.4009 and P/E is -74.43.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | ||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.24M | -1.45M | -814k | 228k | -792k |
| Net Income | -1.53M | -1.68M | -574k | 230k | -774k |
| Year End 30 September 2024 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -7.68M | -13.31M | -6.56M | -2.82M |
| Net Income | -8.65M | -14.97M | -7.37M | -2.8M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | ||
| Total Assets | 6.88M | 6.89M | 6.53M | 6.28M | 6.11M |
| Total Liabilities | 281k | 854k | 846k | 178k | 569k |
| Total Equity | 6.6M | 6.03M | 5.69M | 6.1M | 5.54M |
| Year End 30 September 2024 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 20.04M | 12.09M | 6.88M | 6.11M |
| Total Liabilities | 639k | 1.54M | 281k | 569k |
| Total Equity | 19.4M | 10.54M | 6.6M | 5.54M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | ||
| Operating | -7.03M | -822k | -1.63M | -1.39M | -1.85M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 2.19M | 878k | 856k | 834k | 810k |
| Year End 30 September 2024 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -7.32M | -13.59M | -7.03M | -1.85M |
| Investing | N/A | N/A | N/A | N/A |
| Financing | 26.06M | 5.2M | 2.19M | 810k |
| Market Cap | 208.69M |
| Price to Earnings Ratio | -74.43 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 36.46 |
| Price to Book Ratio | 37.67 |
| Dividend Yield | - |
| Shares Outstanding | 6.99M |
| Average Volume (1 week) | 88.84k |
| Average Volume (1 Month) | 83.36k |
| 52 Week Change | 1,496.79% |
| 52 Week High | 79.02 |
| 52 Week Low | 0.93 |
| Spread (Intraday) | 1.78 (5.75%) |
| Company Name | Bright Minds Biosciences Inc |
| Address |
1500 - 1055 west georgia street vancouver, british columbia V6E 4N7 |
| Website | https://www.brightmindsbio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
